Keywords: gsk, avandia, delays, deterioration, glucose, control, five-year

GSK's Avandia delays deterioration of glucose control, five-year ADOPT data show

Article | 11 December 2006

Print This

UK drug major GlaxoSmithKline presented encouraging results from its ADOPT trial at the 19th World Diabetes Congress of the International ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in